BIOMAT Database Logo BIOMAT Database Logo

[Metastatic breast cancer: controlled treatment trial of chemotherapy combined with hormone therapy using medroxyprogesterone alone or combined with tamoxifen]. 1984

M Jouve, and T Palangie, and B Bretaudeau, and E Garcia-Giralt, and B Asselain, and H Magdelenat, and P Pouillart

UI MeSH Term Description Entries
D008525 Medroxyprogesterone A synthetic progestational hormone used in veterinary practice as an estrus regulator. (6 alpha)-17-Hydroxy-6-methylpregn-4-ene-3,20-dione,Methylhydroxyprogesterone,Pregn-4-ene-3,20-dione, 17-hydroxy-6-methyl-, (6alpha)-,17 alpha-Hydroxy-6 alpha-Methylprogesterone,Adgyn Medro,17 alpha Hydroxy 6 alpha Methylprogesterone
D009362 Neoplasm Metastasis The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. Metastase,Metastasis,Metastases, Neoplasm,Metastasis, Neoplasm,Neoplasm Metastases,Metastases
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000971 Antineoplastic Combined Chemotherapy Protocols The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form. Anticancer Drug Combinations,Antineoplastic Agents, Combined,Antineoplastic Chemotherapy Protocols,Antineoplastic Drug Combinations,Cancer Chemotherapy Protocols,Chemotherapy Protocols, Antineoplastic,Drug Combinations, Antineoplastic,Antineoplastic Combined Chemotherapy Regimens,Combined Antineoplastic Agents,Agent, Combined Antineoplastic,Agents, Combined Antineoplastic,Anticancer Drug Combination,Antineoplastic Agent, Combined,Antineoplastic Chemotherapy Protocol,Antineoplastic Drug Combination,Cancer Chemotherapy Protocol,Chemotherapy Protocol, Antineoplastic,Chemotherapy Protocol, Cancer,Chemotherapy Protocols, Cancer,Combinations, Antineoplastic Drug,Combined Antineoplastic Agent,Drug Combination, Anticancer,Drug Combination, Antineoplastic,Drug Combinations, Anticancer,Protocol, Antineoplastic Chemotherapy,Protocol, Cancer Chemotherapy,Protocols, Antineoplastic Chemotherapy,Protocols, Cancer Chemotherapy
D013629 Tamoxifen One of the SELECTIVE ESTROGEN RECEPTOR MODULATORS with tissue-specific activities. Tamoxifen acts as an anti-estrogen (inhibiting agent) in the mammary tissue, but as an estrogen (stimulating agent) in cholesterol metabolism, bone density, and cell proliferation in the ENDOMETRIUM. ICI-46,474,ICI-46474,ICI-47699,Nolvadex,Novaldex,Soltamox,Tamoxifen Citrate,Tomaxithen,Zitazonium,Citrate, Tamoxifen,ICI 46,474,ICI 46474,ICI 47699,ICI46,474,ICI46474,ICI47699

Related Publications

M Jouve, and T Palangie, and B Bretaudeau, and E Garcia-Giralt, and B Asselain, and H Magdelenat, and P Pouillart
Antitumor effect of lonidamine alone or combined with tamoxifen or medroxyprogesterone acetate in breast cancer cells.
January 1991, Anticancer research,
M Jouve, and T Palangie, and B Bretaudeau, and E Garcia-Giralt, and B Asselain, and H Magdelenat, and P Pouillart
Randomized trial of tamoxifen alone or combined with aminoglutethimide and hydrocortisone in women with metastatic breast cancer.
June 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
M Jouve, and T Palangie, and B Bretaudeau, and E Garcia-Giralt, and B Asselain, and H Magdelenat, and P Pouillart
Randomized clinical trial of tamoxifen alone or combined with fluoxymesterone in postmenopausal women with metastatic breast cancer.
May 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
M Jouve, and T Palangie, and B Bretaudeau, and E Garcia-Giralt, and B Asselain, and H Magdelenat, and P Pouillart
A randomized trial of tamoxifen alone or combined with octreotide in the treatment of women with metastatic breast carcinoma.
March 1999, Cancer,
M Jouve, and T Palangie, and B Bretaudeau, and E Garcia-Giralt, and B Asselain, and H Magdelenat, and P Pouillart
Antiproliferative effect of leuprorelin acetate, alone or combined with tamoxifen or medroxyprogesterone acetate, on human breast cancer cell lines.
January 1992, Clinical therapeutics,
M Jouve, and T Palangie, and B Bretaudeau, and E Garcia-Giralt, and B Asselain, and H Magdelenat, and P Pouillart
Treatment of metastatic breast cancer with aminoglutethimide after progression on chemotherapy and/or hormonal therapy with tamoxifen.
March 1985, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology,
M Jouve, and T Palangie, and B Bretaudeau, and E Garcia-Giralt, and B Asselain, and H Magdelenat, and P Pouillart
Randomized trial of adjuvant tamoxifen combined with postoperative radiation therapy or adjuvant chemotherapy in postmenopausal breast cancer.
July 1990, Cancer,
M Jouve, and T Palangie, and B Bretaudeau, and E Garcia-Giralt, and B Asselain, and H Magdelenat, and P Pouillart
Tamoxifen versus medroxyprogesterone acetate for metastatic breast cancer.
November 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
M Jouve, and T Palangie, and B Bretaudeau, and E Garcia-Giralt, and B Asselain, and H Magdelenat, and P Pouillart
Cyclic and sequential therapy with tamoxifen and medroxyprogesterone acetate in metastatic breast cancer.
August 1989, Journal of surgical oncology,
M Jouve, and T Palangie, and B Bretaudeau, and E Garcia-Giralt, and B Asselain, and H Magdelenat, and P Pouillart
Chemotherapy alone versus endocrine therapy alone for metastatic breast cancer.
January 2003, The Cochrane database of systematic reviews,
Copied contents to your clipboard!